Jeffrey Stambough
Concepts (255)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthroplasty, Replacement, Hip | 51 | 2024 | 268 | 14.640 |
Why?
| | Arthroplasty, Replacement, Knee | 43 | 2025 | 289 | 13.050 |
Why?
| | Prosthesis-Related Infections | 11 | 2024 | 109 | 5.620 |
Why?
| | Knee Prosthesis | 9 | 2025 | 52 | 3.350 |
Why?
| | Hip Prosthesis | 9 | 2022 | 73 | 2.620 |
Why?
| | Reoperation | 18 | 2024 | 476 | 2.430 |
Why?
| | Osteoarthritis, Knee | 8 | 2025 | 97 | 2.390 |
Why?
| | Patient Readmission | 11 | 2024 | 251 | 2.280 |
Why?
| | Anesthesia, General | 4 | 2024 | 99 | 2.130 |
Why?
| | Retrospective Studies | 43 | 2025 | 6819 | 1.940 |
Why?
| | Knee Joint | 17 | 2025 | 166 | 1.860 |
Why?
| | Postoperative Complications | 11 | 2024 | 1099 | 1.800 |
Why?
| | Arthritis, Infectious | 4 | 2023 | 45 | 1.710 |
Why?
| | Orthopedics | 5 | 2022 | 54 | 1.660 |
Why?
| | Arthroplasty | 5 | 2023 | 26 | 1.620 |
Why?
| | Humans | 93 | 2026 | 53230 | 1.500 |
Why?
| | Length of Stay | 10 | 2024 | 684 | 1.380 |
Why?
| | Pneumonia, Viral | 4 | 2020 | 177 | 1.280 |
Why?
| | Coronavirus Infections | 4 | 2020 | 188 | 1.260 |
Why?
| | Anti-Bacterial Agents | 5 | 2024 | 830 | 1.250 |
Why?
| | Hospitals | 6 | 2024 | 181 | 1.190 |
Why?
| | Femoral Fractures | 3 | 2023 | 40 | 1.140 |
Why?
| | Aged | 30 | 2025 | 10429 | 1.050 |
Why?
| | Opioid-Related Disorders | 5 | 2024 | 426 | 1.050 |
Why?
| | Osteoarthritis, Hip | 3 | 2016 | 28 | 1.040 |
Why?
| | Patient Discharge | 6 | 2022 | 325 | 1.010 |
Why?
| | Treatment Outcome | 19 | 2025 | 5595 | 1.000 |
Why?
| | Polyethylene | 5 | 2020 | 18 | 0.990 |
Why?
| | Joint Instability | 4 | 2022 | 44 | 0.990 |
Why?
| | Hip Fractures | 2 | 2023 | 46 | 0.960 |
Why?
| | Obesity, Morbid | 2 | 2024 | 86 | 0.930 |
Why?
| | Medicare | 10 | 2024 | 280 | 0.910 |
Why?
| | Debridement | 2 | 2024 | 49 | 0.910 |
Why?
| | Anesthesia, Spinal | 2 | 2022 | 17 | 0.910 |
Why?
| | Perioperative Care | 2 | 2016 | 44 | 0.900 |
Why?
| | Registries | 5 | 2024 | 652 | 0.890 |
Why?
| | Pandemics | 6 | 2022 | 595 | 0.860 |
Why?
| | United States | 21 | 2024 | 5409 | 0.860 |
Why?
| | Femur | 5 | 2023 | 133 | 0.840 |
Why?
| | Femur Head | 4 | 2019 | 26 | 0.840 |
Why?
| | Prosthesis Failure | 6 | 2024 | 113 | 0.820 |
Why?
| | Aged, 80 and over | 13 | 2025 | 3494 | 0.820 |
Why?
| | Osteotomy | 3 | 2018 | 32 | 0.800 |
Why?
| | Pain, Postoperative | 8 | 2024 | 169 | 0.790 |
Why?
| | Femoral Neck Fractures | 2 | 2022 | 7 | 0.790 |
Why?
| | Body Mass Index | 2 | 2024 | 717 | 0.780 |
Why?
| | Knee Injuries | 1 | 2023 | 28 | 0.780 |
Why?
| | Male | 32 | 2025 | 27435 | 0.780 |
Why?
| | Middle Aged | 25 | 2025 | 13419 | 0.770 |
Why?
| | Anemia | 1 | 2023 | 76 | 0.770 |
Why?
| | Osteoarthritis | 1 | 2023 | 61 | 0.750 |
Why?
| | Bariatric Surgery | 1 | 2023 | 44 | 0.750 |
Why?
| | Female | 33 | 2025 | 28782 | 0.740 |
Why?
| | Analgesics, Opioid | 8 | 2024 | 622 | 0.740 |
Why?
| | Prosthesis Design | 10 | 2024 | 266 | 0.690 |
Why?
| | Anti-Infective Agents, Local | 1 | 2021 | 28 | 0.660 |
Why?
| | Acetabulum | 4 | 2020 | 39 | 0.630 |
Why?
| | Narcotics | 1 | 2020 | 108 | 0.630 |
Why?
| | Skilled Nursing Facilities | 2 | 2022 | 9 | 0.620 |
Why?
| | Patient Satisfaction | 2 | 2022 | 292 | 0.610 |
Why?
| | Arthralgia | 2 | 2022 | 44 | 0.610 |
Why?
| | Diabetes Mellitus | 1 | 2023 | 321 | 0.610 |
Why?
| | Medicaid | 2 | 2019 | 294 | 0.600 |
Why?
| | Range of Motion, Articular | 6 | 2023 | 110 | 0.600 |
Why?
| | Blood Sedimentation | 1 | 2019 | 16 | 0.590 |
Why?
| | Societies, Medical | 2 | 2023 | 207 | 0.590 |
Why?
| | Obesity | 2 | 2024 | 1204 | 0.590 |
Why?
| | Bone Anteversion | 1 | 2018 | 2 | 0.590 |
Why?
| | Bone Nails | 1 | 2018 | 11 | 0.580 |
Why?
| | Risk Factors | 10 | 2024 | 4017 | 0.580 |
Why?
| | C-Reactive Protein | 1 | 2019 | 152 | 0.550 |
Why?
| | Time-to-Treatment | 1 | 2019 | 81 | 0.540 |
Why?
| | Mupirocin | 1 | 2016 | 4 | 0.510 |
Why?
| | Chlorhexidine | 1 | 2016 | 12 | 0.500 |
Why?
| | Quadriceps Muscle | 3 | 2022 | 47 | 0.490 |
Why?
| | Hip Joint | 2 | 2015 | 59 | 0.480 |
Why?
| | Practice Guidelines as Topic | 1 | 2019 | 502 | 0.480 |
Why?
| | Spinal Stenosis | 2 | 2010 | 12 | 0.470 |
Why?
| | Surgical Wound Infection | 1 | 2016 | 118 | 0.470 |
Why?
| | Adult | 17 | 2024 | 14534 | 0.460 |
Why?
| | Pelvic Bones | 1 | 2015 | 13 | 0.450 |
Why?
| | Prospective Studies | 6 | 2021 | 2411 | 0.450 |
Why?
| | Time Factors | 7 | 2024 | 2991 | 0.440 |
Why?
| | Clinical Protocols | 1 | 2015 | 109 | 0.430 |
Why?
| | Bone Transplantation | 2 | 2013 | 43 | 0.410 |
Why?
| | Patient Care Team | 1 | 2016 | 278 | 0.400 |
Why?
| | Curettage | 1 | 2013 | 12 | 0.400 |
Why?
| | Humerus | 1 | 2013 | 17 | 0.400 |
Why?
| | Capillaries | 1 | 2013 | 53 | 0.390 |
Why?
| | Decompression, Surgical | 1 | 2013 | 50 | 0.390 |
Why?
| | Tibia | 3 | 2023 | 118 | 0.390 |
Why?
| | Periprosthetic Fractures | 2 | 2023 | 11 | 0.380 |
Why?
| | Osteocytes | 2 | 2024 | 227 | 0.340 |
Why?
| | Pain | 6 | 2024 | 351 | 0.340 |
Why?
| | Lumbar Vertebrae | 2 | 2022 | 101 | 0.340 |
Why?
| | Quality Indicators, Health Care | 2 | 2024 | 92 | 0.330 |
Why?
| | Radiography | 3 | 2019 | 476 | 0.320 |
Why?
| | Intervertebral Disc Degeneration | 1 | 2010 | 5 | 0.320 |
Why?
| | Muscle Strength | 2 | 2022 | 132 | 0.320 |
Why?
| | Follow-Up Studies | 5 | 2019 | 2318 | 0.300 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2010 | 67 | 0.300 |
Why?
| | Pain Measurement | 3 | 2024 | 259 | 0.300 |
Why?
| | Transforming Growth Factor beta | 1 | 2010 | 136 | 0.300 |
Why?
| | Spinal Fusion | 1 | 2010 | 73 | 0.290 |
Why?
| | Recombinant Proteins | 1 | 2010 | 489 | 0.280 |
Why?
| | Incidence | 2 | 2024 | 1085 | 0.270 |
Why?
| | Adolescent | 6 | 2019 | 6907 | 0.260 |
Why?
| | Osteolysis | 2 | 2018 | 74 | 0.250 |
Why?
| | Tertiary Care Centers | 2 | 2023 | 86 | 0.240 |
Why?
| | Referral and Consultation | 2 | 2020 | 299 | 0.240 |
Why?
| | Young Adult | 5 | 2019 | 4511 | 0.220 |
Why?
| | Single-Cell Analysis | 1 | 2024 | 72 | 0.210 |
Why?
| | Prospective Payment System | 1 | 2024 | 6 | 0.210 |
Why?
| | Leg Injuries | 1 | 2024 | 11 | 0.210 |
Why?
| | Endrin | 1 | 2023 | 3 | 0.210 |
Why?
| | Nerve Block | 1 | 2024 | 42 | 0.210 |
Why?
| | Tibial Fractures | 1 | 2024 | 34 | 0.210 |
Why?
| | Aftercare | 2 | 2022 | 73 | 0.200 |
Why?
| | Polyethylenes | 1 | 2023 | 14 | 0.200 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2026 | 350 | 0.200 |
Why?
| | Systemic Inflammatory Response Syndrome | 1 | 2023 | 63 | 0.190 |
Why?
| | International Classification of Diseases | 1 | 2023 | 70 | 0.190 |
Why?
| | Recurrence | 1 | 2024 | 694 | 0.190 |
Why?
| | Transplantation, Homologous | 1 | 2023 | 154 | 0.190 |
Why?
| | Mechanotransduction, Cellular | 1 | 2023 | 42 | 0.190 |
Why?
| | Bone Neoplasms | 1 | 2024 | 188 | 0.190 |
Why?
| | Lordosis | 1 | 2022 | 4 | 0.190 |
Why?
| | Bone Diseases, Metabolic | 1 | 2023 | 79 | 0.190 |
Why?
| | Osteonecrosis | 1 | 2022 | 35 | 0.190 |
Why?
| | Crowdsourcing | 1 | 2022 | 10 | 0.190 |
Why?
| | Kyphosis | 1 | 2022 | 17 | 0.180 |
Why?
| | Quality of Life | 3 | 2022 | 902 | 0.180 |
Why?
| | Disability Evaluation | 2 | 2019 | 92 | 0.180 |
Why?
| | Leg | 1 | 2022 | 123 | 0.180 |
Why?
| | Metal-on-Metal Joint Prostheses | 1 | 2021 | 5 | 0.180 |
Why?
| | Cost of Illness | 1 | 2022 | 121 | 0.180 |
Why?
| | Anemia, Sickle Cell | 1 | 2022 | 105 | 0.170 |
Why?
| | alpha-Defensins | 1 | 2021 | 3 | 0.170 |
Why?
| | Hospitalization | 2 | 2023 | 749 | 0.170 |
Why?
| | Bone Resorption | 1 | 2023 | 304 | 0.170 |
Why?
| | Therapeutic Irrigation | 1 | 2021 | 27 | 0.170 |
Why?
| | Weight Loss | 1 | 2023 | 257 | 0.170 |
Why?
| | Cohort Studies | 3 | 2022 | 1557 | 0.170 |
Why?
| | North America | 1 | 2020 | 75 | 0.160 |
Why?
| | Polyradiculopathy | 1 | 2000 | 4 | 0.160 |
Why?
| | Salvage Therapy | 1 | 2021 | 138 | 0.160 |
Why?
| | Chromium | 2 | 2021 | 5 | 0.160 |
Why?
| | Cobalt | 2 | 2021 | 16 | 0.160 |
Why?
| | Workload | 1 | 2020 | 48 | 0.160 |
Why?
| | Anesthesia, Epidural | 1 | 2000 | 26 | 0.160 |
Why?
| | Health Planning Guidelines | 1 | 2019 | 11 | 0.150 |
Why?
| | Hemiarthroplasty | 1 | 2019 | 6 | 0.150 |
Why?
| | Comorbidity | 2 | 2018 | 638 | 0.150 |
Why?
| | Leadership | 1 | 2020 | 106 | 0.150 |
Why?
| | New York City | 1 | 2019 | 26 | 0.150 |
Why?
| | Insurance, Health, Reimbursement | 1 | 2019 | 24 | 0.150 |
Why?
| | North Carolina | 1 | 2019 | 53 | 0.150 |
Why?
| | Physical Examination | 1 | 2019 | 96 | 0.150 |
Why?
| | Social Media | 1 | 2021 | 125 | 0.150 |
Why?
| | Rotation | 1 | 2018 | 44 | 0.140 |
Why?
| | Health Resources | 1 | 2019 | 72 | 0.140 |
Why?
| | Sepsis | 1 | 2021 | 240 | 0.140 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2019 | 54 | 0.140 |
Why?
| | Insurance Claim Review | 1 | 2018 | 42 | 0.140 |
Why?
| | Rural Population | 1 | 2023 | 596 | 0.140 |
Why?
| | Recovery of Function | 2 | 2016 | 203 | 0.140 |
Why?
| | Electronic Health Records | 1 | 2021 | 287 | 0.140 |
Why?
| | Imaging, Three-Dimensional | 2 | 2016 | 145 | 0.140 |
Why?
| | Insurance, Health | 1 | 2019 | 146 | 0.130 |
Why?
| | Joint Diseases | 1 | 2018 | 40 | 0.130 |
Why?
| | Administration, Intranasal | 1 | 2016 | 30 | 0.130 |
Why?
| | Osteoclasts | 3 | 2024 | 428 | 0.130 |
Why?
| | Missouri | 1 | 2016 | 67 | 0.120 |
Why?
| | Child | 3 | 2019 | 7379 | 0.120 |
Why?
| | Predictive Value of Tests | 1 | 2019 | 934 | 0.120 |
Why?
| | Hospital Costs | 1 | 2016 | 74 | 0.120 |
Why?
| | Ceramics | 1 | 2015 | 5 | 0.120 |
Why?
| | Computer-Aided Design | 1 | 2016 | 20 | 0.120 |
Why?
| | Eligibility Determination | 1 | 2016 | 22 | 0.120 |
Why?
| | Breast Neoplasms | 1 | 2024 | 1222 | 0.120 |
Why?
| | Hip Dislocation | 1 | 2015 | 17 | 0.120 |
Why?
| | Viscosupplementation | 1 | 2015 | 1 | 0.120 |
Why?
| | Cost-Benefit Analysis | 1 | 2016 | 274 | 0.110 |
Why?
| | Lower Extremity | 3 | 2024 | 103 | 0.110 |
Why?
| | Weight-Bearing | 1 | 2015 | 45 | 0.110 |
Why?
| | Cartilage, Articular | 1 | 2015 | 47 | 0.110 |
Why?
| | Biocompatible Materials | 1 | 2015 | 67 | 0.110 |
Why?
| | Treatment Failure | 1 | 2014 | 119 | 0.110 |
Why?
| | Patient Safety | 1 | 2015 | 103 | 0.100 |
Why?
| | Patient Selection | 1 | 2016 | 273 | 0.100 |
Why?
| | Mice | 4 | 2026 | 5982 | 0.100 |
Why?
| | Staphylococcal Infections | 1 | 2016 | 271 | 0.100 |
Why?
| | Quality Improvement | 1 | 2016 | 230 | 0.100 |
Why?
| | Staphylococcus aureus | 1 | 2016 | 313 | 0.100 |
Why?
| | Calcium Sulfate | 1 | 2013 | 7 | 0.100 |
Why?
| | Motor Activity | 1 | 2014 | 227 | 0.100 |
Why?
| | Sex Factors | 1 | 2015 | 747 | 0.100 |
Why?
| | Arkansas | 1 | 2019 | 2068 | 0.100 |
Why?
| | Magnetic Resonance Imaging | 2 | 2016 | 1583 | 0.090 |
Why?
| | Age Factors | 1 | 2014 | 1136 | 0.090 |
Why?
| | Multiple Myeloma | 1 | 2026 | 3082 | 0.090 |
Why?
| | Cell Line, Tumor | 2 | 2026 | 1470 | 0.090 |
Why?
| | Outpatients | 2 | 2022 | 131 | 0.080 |
Why?
| | Postoperative Period | 2 | 2023 | 169 | 0.080 |
Why?
| | Bone Morphogenetic Protein 2 | 1 | 2010 | 48 | 0.080 |
Why?
| | Bone Cements | 2 | 2022 | 30 | 0.080 |
Why?
| | Animals | 4 | 2026 | 13526 | 0.070 |
Why?
| | Inpatients | 2 | 2022 | 208 | 0.070 |
Why?
| | Severity of Illness Index | 1 | 2010 | 1049 | 0.060 |
Why?
| | Prevalence | 2 | 2022 | 1034 | 0.060 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2026 | 228 | 0.060 |
Why?
| | Spinal Cord Compression | 1 | 2004 | 13 | 0.050 |
Why?
| | Child, Preschool | 1 | 2013 | 4162 | 0.050 |
Why?
| | Spinal Neoplasms | 1 | 2004 | 30 | 0.050 |
Why?
| | Osteoprotegerin | 1 | 2023 | 53 | 0.050 |
Why?
| | Hemangioma | 1 | 2004 | 86 | 0.050 |
Why?
| | Knee | 1 | 2023 | 25 | 0.050 |
Why?
| | Acute Disease | 2 | 2004 | 393 | 0.050 |
Why?
| | Fracture Fixation, Internal | 1 | 2023 | 45 | 0.050 |
Why?
| | Pain Management | 1 | 2024 | 185 | 0.050 |
Why?
| | Ion Channels | 1 | 2023 | 70 | 0.050 |
Why?
| | Tumor Microenvironment | 1 | 2024 | 274 | 0.050 |
Why?
| | Pelvis | 1 | 2022 | 66 | 0.050 |
Why?
| | Transcriptome | 1 | 2024 | 367 | 0.050 |
Why?
| | Femur Neck | 1 | 2021 | 6 | 0.040 |
Why?
| | Synovial Fluid | 1 | 2021 | 17 | 0.040 |
Why?
| | Maryland | 1 | 2020 | 29 | 0.040 |
Why?
| | New York | 1 | 2020 | 52 | 0.040 |
Why?
| | Kentucky | 1 | 2020 | 47 | 0.040 |
Why?
| | Florida | 1 | 2020 | 70 | 0.040 |
Why?
| | Socioeconomic Factors | 1 | 2023 | 623 | 0.040 |
Why?
| | Postural Balance | 1 | 2021 | 59 | 0.040 |
Why?
| | Disease Models, Animal | 1 | 2026 | 1517 | 0.040 |
Why?
| | Dissociative Disorders | 1 | 2020 | 9 | 0.040 |
Why?
| | Research Design | 1 | 2022 | 373 | 0.040 |
Why?
| | Cross-Over Studies | 1 | 2021 | 241 | 0.040 |
Why?
| | Gait | 1 | 2021 | 90 | 0.040 |
Why?
| | Osteoblasts | 1 | 2023 | 480 | 0.040 |
Why?
| | Gene Expression Profiling | 1 | 2024 | 1112 | 0.040 |
Why?
| | Bone and Bones | 1 | 2023 | 501 | 0.040 |
Why?
| | Chromium Alloys | 1 | 2019 | 5 | 0.040 |
Why?
| | Signal Transduction | 1 | 2026 | 1748 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2021 | 867 | 0.040 |
Why?
| | Mortality | 1 | 2019 | 98 | 0.040 |
Why?
| | Reproducibility of Results | 1 | 2022 | 1219 | 0.040 |
Why?
| | Morbidity | 1 | 2019 | 132 | 0.040 |
Why?
| | Antineoplastic Agents | 1 | 2026 | 1232 | 0.030 |
Why?
| | Muscle, Skeletal | 1 | 2022 | 815 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2019 | 774 | 0.030 |
Why?
| | Awards and Prizes | 1 | 2016 | 17 | 0.030 |
Why?
| | Ankle Joint | 1 | 2015 | 22 | 0.030 |
Why?
| | Chi-Square Distribution | 1 | 2016 | 291 | 0.030 |
Why?
| | Databases, Factual | 1 | 2016 | 742 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2016 | 1180 | 0.020 |
Why?
| | Thoracic Vertebrae | 1 | 2004 | 38 | 0.010 |
Why?
|
|
Stambough's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|